BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 25481873)

  • 21. Tissue transglutaminase regulates focal adhesion kinase/AKT activation by modulating PTEN expression in pancreatic cancer cells.
    Verma A; Guha S; Wang H; Fok JY; Koul D; Abbruzzese J; Mehta K
    Clin Cancer Res; 2008 Apr; 14(7):1997-2005. PubMed ID: 18381937
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Methylation characteristics and developmental potential of Guangxi Bama minipig (Sus scrofa domestica) cloned embryos from donor cells treated with trichostatin A and 5-aza-2'-deoxycytidine.
    Ning SF; Li QY; Liang MM; Yang XG; Xu HY; Lu YQ; Lu SS; Lu KH
    Zygote; 2013 May; 21(2):178-86. PubMed ID: 22355002
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of DNA methyltransferase activates tumor necrosis factor alpha-induced monocytic differentiation in acute myeloid leukemia cells.
    Laurenzana A; Petruccelli LA; Pettersson F; Figueroa ME; Melnick A; Baldwin AS; Paoletti F; Miller WH
    Cancer Res; 2009 Jan; 69(1):55-64. PubMed ID: 19117987
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An integrated humoral and cellular response is elicited in pancreatic cancer by alpha-enolase, a novel pancreatic ductal adenocarcinoma-associated antigen.
    Cappello P; Tomaino B; Chiarle R; Ceruti P; Novarino A; Castagnoli C; Migliorini P; Perconti G; Giallongo A; Milella M; Monsurrò V; Barbi S; Scarpa A; Nisticò P; Giovarelli M; Novelli F
    Int J Cancer; 2009 Aug; 125(3):639-48. PubMed ID: 19425054
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overexpression of PD2 leads to increased tumorigenicity and metastasis in pancreatic ductal adenocarcinoma.
    Vaz AP; Deb S; Rachagani S; Dey P; Muniyan S; Lakshmanan I; Karmakar S; Smith L; Johansson S; Lele S; Ouellette M; Ponnusamy MP; Batra SK
    Oncotarget; 2016 Jan; 7(3):3317-31. PubMed ID: 26689992
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Magnetic resonance imaging monitors physiological changes with antihedgehog therapy in pancreatic adenocarcinoma xenograft model.
    Guimaraes AR; Rakhlin E; Weissleder R; Thayer SP
    Pancreas; 2008 Nov; 37(4):440-4. PubMed ID: 18953259
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interobserver agreement and accuracy of preoperative endoscopic ultrasound-guided biopsy for histological grading of pancreatic cancer.
    Larghi A; Correale L; Ricci R; Abdulkader I; Monges G; Iglesias-Garcia J; Giovannini M; Attili F; Vitale G; Hassan C; Costamagna G; Rindi G
    Endoscopy; 2015 Apr; 47(4):308-14. PubMed ID: 25521572
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pancreatic Adenocarcinoma Therapeutic Targets Revealed by Tumor-Stroma Cross-Talk Analyses in Patient-Derived Xenografts.
    Nicolle R; Blum Y; Marisa L; Loncle C; Gayet O; Moutardier V; Turrini O; Giovannini M; Bian B; Bigonnet M; Rubis M; Elarouci N; Armenoult L; Ayadi M; Duconseil P; Gasmi M; Ouaissi M; Maignan A; Lomberk G; Boher JM; Ewald J; Bories E; Garnier J; Goncalves A; Poizat F; Raoul JL; Secq V; Garcia S; Grandval P; Barraud-Blanc M; Norguet E; Gilabert M; Delpero JR; Roques J; Calvo E; Guillaumond F; Vasseur S; Urrutia R; de Reyniès A; Dusetti N; Iovanna J
    Cell Rep; 2017 Nov; 21(9):2458-2470. PubMed ID: 29186684
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of c-Myc by 10058-F4 induces growth arrest and chemosensitivity in pancreatic ductal adenocarcinoma.
    Zhang M; Fan HY; Li SC
    Biomed Pharmacother; 2015 Jul; 73():123-8. PubMed ID: 26211592
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Methylation status of promoters and expression of MUC2 and MUC5AC mucins in pancreatic cancer cells.
    Ho JJ; Han SW; Pan PL; Deng G; Kuan SF; Kim YS
    Int J Oncol; 2003 Feb; 22(2):273-9. PubMed ID: 12527922
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnostic approach to pancreatic tumors with the specimens of endoscopic ultrasound-guided fine needle aspiration.
    Hosoda W; Takagi T; Mizuno N; Shimizu Y; Sano T; Yamao K; Yatabe Y
    Pathol Int; 2010 May; 60(5):358-64. PubMed ID: 20518885
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SERPINB5 Promoter Hypomethylation Differentiates Pancreatic Ductal Adenocarcinoma From Pancreatitis.
    Mardin WA; Ntalos D; Mees ST; Spieker T; Senninger N; Haier J; Dhayat SA
    Pancreas; 2016; 45(5):743-7. PubMed ID: 26646275
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Innovative Experimental Ultrasound and US-Related Techniques Using the Murine Model in Pancreatic Ductal Adenocarcinoma: A Systematic Review.
    Coppola A; Grasso D; Fontana F; Piacentino F; Minici R; Laganà D; Ierardi AM; Carrafiello G; D'Angelo F; Carcano G; Venturini M
    J Clin Med; 2023 Dec; 12(24):. PubMed ID: 38137745
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combining the antianginal drug perhexiline with chemotherapy induces complete pancreatic cancer regression
    Reyes-Castellanos G; Abdel Hadi N; Gallardo-Arriaga S; Masoud R; Garcia J; Lac S; El Kaoutari A; Gicquel T; Planque M; Fendt SM; Linares LK; Gayet O; Guillaumond F; Dusetti N; Iovanna J; Carrier A
    iScience; 2023 Jun; 26(6):106899. PubMed ID: 37305702
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preclinical models derived from endoscopic ultrasound-guided tissue acquisition for individualized treatment of pancreatic ductal adenocarcinoma.
    Tong T; Zhang C; Li J; Deng M; Wang X
    Front Med (Lausanne); 2022; 9():934974. PubMed ID: 36687406
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Induction of Apoptosis in Human Pancreatic Cancer Stem Cells by the Endoplasmic Reticulum-Targeted Alkylphospholipid Analog Edelfosine and Potentiation by Autophagy Inhibition.
    Gajate C; Gayet O; Fraunhoffer NA; Iovanna J; Dusetti N; Mollinedo F
    Cancers (Basel); 2021 Dec; 13(23):. PubMed ID: 34885233
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeting Mitochondrial Complex I Overcomes Chemoresistance in High OXPHOS Pancreatic Cancer.
    Masoud R; Reyes-Castellanos G; Lac S; Garcia J; Dou S; Shintu L; Abdel Hadi N; Gicquel T; El Kaoutari A; Diémé B; Tranchida F; Cormareche L; Borge L; Gayet O; Pasquier E; Dusetti N; Iovanna J; Carrier A
    Cell Rep Med; 2020 Nov; 1(8):100143. PubMed ID: 33294863
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pancreatic Cancer Heterogeneity Can Be Explained Beyond the Genome.
    Juiz NA; Iovanna J; Dusetti N
    Front Oncol; 2019; 9():246. PubMed ID: 31024848
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Trefoil factor(s) and CA19.9: A promising panel for early detection of pancreatic cancer.
    Jahan R; Ganguly K; Smith LM; Atri P; Carmicheal J; Sheinin Y; Rachagani S; Natarajan G; Brand RE; Macha MA; Grandgenett PM; Kaur S; Batra SK
    EBioMedicine; 2019 Apr; 42():375-385. PubMed ID: 30956167
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DNA methylation inhibitor attenuates polyglutamine-induced neurodegeneration by regulating Hes5.
    Kondo N; Tohnai G; Sahashi K; Iida M; Kataoka M; Nakatsuji H; Tsutsumi Y; Hashizume A; Adachi H; Koike H; Shinjo K; Kondo Y; Sobue G; Katsuno M
    EMBO Mol Med; 2019 May; 11(5):. PubMed ID: 30940675
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.